Syndax Pharmaceuticals, Inc. (SNDX)
19.62
-0.28
(-1.38%)
USD |
NASDAQ |
May 27, 16:00
19.62
0.00 (0.00%)
After-Hours: 16:39
Syndax Pharmaceuticals Cash from Investing (Quarterly) : 38.39M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -36.46M |
| Vera Therapeutics, Inc. | -137.82M |
| Biogen, Inc. | -209.50M |
| Amgen, Inc. | -716.00M |
| Ardelyx, Inc. | -9.995M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -50.34M |
| Cash from Financing (Quarterly) | 7.918M |
| Free Cash Flow | -278.35M |
| Free Cash Flow Per Share (Quarterly) | -0.5704 |
| Free Cash Flow to Equity (Quarterly) | -50.27M |
| Free Cash Flow to Firm (Quarterly) | -38.50M |
| Free Cash Flow Yield | -16.28% |